Analysis of Swab and Viral Transport Medium market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Demand in the swab and viral and transport medium market has witnessed remarkable upsurge in the recent past, as the number of tests and laboratory experiments are registering an unprecedented high during the COVID-19 pandemic.
While the pandemic is currently acting as a catalyst for market growth, growing emphasis by market players on the development of advanced testing processes such as rapid antigen testing and molecular essay experiments will aid in sustaining demand in the long run.
Swab and viral transport medium aid microbiologists in collecting, transporting, and preserving biological samples meant for testing & research purposes. To curb the spread of the infection, governments across the world are working closely with healthcare technology service providers to ensure wide-scale testing of COVID-19 infections.
In addition to the ongoing trend of COVID-19 infection, prevalence of commonly-transmitted diseases such as influenza and herpes will continue to drive demand in the swab and viral transport medium market after the COVID-19 outbreak is contained.
These factors will continue to act as tailwinds to the expansion of the swab and viral and transport medium market size.
Market players are capitalizing the growing number of infections, and are up-scaling their production capacities and offerings to facilitate efficient storage options for biosamples. Impelled by these factors, Fact.MR, in a new study, has projected that the global swab and viral transport medium market will surpass a valuation of US$ 2.2 Bn by the end of 2030.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
Over the years, there has been considerable improvements in swabs, with innovations such as double-ended flocked swabs, kits with integrated vials, etc., which have been aiding the growth of the swab and viral transport medium market.
On these lines, there are different types of swabs for different infections, such as nasal swabs, nasopharyngeal swabs, and throat swabs, which will continue to bestow lucrative revenue opportunities.
On the other hand, the transport medium is expected to drive a majority of market revenue. High demand for transport is attributable to continual need for transporting viruses, chlamydia, and mycoplasms for research, including conventional cell culture methods, diagnostic tests, and molecular biology techniques.
Moreover, backed by raising awareness regarding preventable infectious diseases across the world, the transport medium will grow at a rapid pace over the coming years.
Swab and viral transport medium find application in viral infection diagnosis to detect the presence of several contagious viruses such as influenza, herpes simplex virus, varicella-zoster virus, and respiratory syncytial virus, among others. Of these, adoption to detect influenza is expected to remain the most lucrative application.
The dominance of this segment can be attributed to the high prevalence of the infection across the world, and the availability of proper medical infrastructure in developed economies.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
On the basis of end use, the swab and viral transport medium market is categorized into hospitals & clinics, microbiology laboratories, diagnostic laboratories, and others. Among these, the hospitals & clinics segment is poised to hold a lion’s share in the market value, owing to the high number of patient visits.
For instance, CDC estimated that, the number of medical visits in the U.S. ranged between 18 Mn and 26 Mn from October 2019 to April 2020. This number represents a significant rise from the previous year, and is only expected to go upwards.
Regionally, the report on the swab and viral transport medium market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Among these regions, North America is foreseen to spearhead the regional landscape through the assessment period, owing to the presence of advanced medical infrastructure coupled with high prevalence of infectious diseases in the region.
Expansion of the market in the region is also bolstered by rising expenditure by the government to develop healthcare processes and technologies to curb the mortality rates of infectious diseases.
Along similar lines, Asia Pacific is expected to hold the second-largest swab and viral transport medium market share, on the back of a wide base of geriatric population that is highly vulnerable to infectious diseases, coupled with the presence of a developing medical network in emerging economies such as India and China.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Players operating in the swab and viral transport medium market are adopting strategies such as new product launches and expansion of manufacturing capabilities to gain an edge in this competitive landscape.
Furthermore, players are focusing on developing products that enable efficient and accurate rapid antigen testing, viral culture, and molecular-based assays. To achieve the same, they are adopting novel technologies such as 3D printing and are investing in research & development activities.
To study the competition prevailing in the swab and viral transport medium market, Fact.MR profiles some of the leading players in this space. These include companies such as Thermo Fisher Scientific, Becton, Dickinson and Company, MWE, Titan Biotech Ltd, COPAN Diagnostics Inc., MANTACC, Puritan Medical Products, YOCON Biology, Trinity Biotech, and VIRCELL S.L.
"As governments and healthcare institutions across the world prioritize curbing COVID-19 infection rates, increasing emphasis on infection control is boosting revenue of the global swab and viral transport medium market,"
As the number of COVID-19 infections rises across the world, demand for swab and viral transport has never been higher, and this has created a gargantuan revenue opportunity for the swab and viral transport medium market.
Between January and October 2020, the number of tests in the U.S. and Russia surged past 118 Mn and 51 Mn, respectively.
This also indicates unprecedented demand for swabs and the transport medium. With no vaccine ready, governments across the world are resorting to testing, considering it as the most effective way to control the spread of the infection, thereby ensuring that demand for swab and viral transport medium persists throughout the pandemic.
Fact.MR has published an exclusive forecast report on the swab and viral transport medium market for 2020 and 2030. The foremost objective of this report is to offer spearhead insights on the market scenario, demand generators, and technological advancements into the market. Also, the study addresses key dynamics that are expected to diversify the sales and future prospects for the market.
The report on the swab and viral transport medium market begins with an executive overview, in which, product definition has been provided. The report further proceeds with the taxonomy of the swab and viral transport medium market, elaborating on key segments. Also, the report outlines visionary insights on the dynamics of the market, including the drivers, restraints, opportunities, trends, and pricing analysis, along with the key factors favoring investment within the market.
Supply chain analysis and pricing analysis of the market, along with the difference between swab and viral transport medium used as per application, have also been included in the report, to help readers clearly understand the product framework map in the swab and viral transport medium market.
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Research Methodology -
An Adaptive Approach to Modern-day Research NeedsGet Methodology
- Related Reports -
The global swab and viral transport medium market will surpass a valuation of US$ 2.2 Bn by 2030.
The transport medium is expected to drive a majority of market revenue.
Thermo Fisher Scientific, Becton, Dickinson and Company, MWE, Titan Biotech Ltd, COPAN Diagnostics Inc. and others
Need An Exclusive Report For Your Unique Requirement?